| Power-Pak C.E. is pleased to present a complimentary CE WEBINAR |
|
|
|
|
Goal To provide oncology nurses, nurse practitioners, and pharmacists with advanced and up-to-date knowledge of immune checkpoint inhibitors alone or in combination with other agents for the treatment of cancer, enhance their confidence and competence in identifying and recommending appropriate patient-specific treatments and developing optimal toxicity prevention and management strategies, thus leading to improved patient outcomes during the COVID-19 pandemic and beyond. |
|
|
Learning Objectives Upon completion of this activity, participants should be better able to: |
|
• |
Discuss the current and emerging use of immune checkpoint inhibitors (ICIs) and ICI combination regimens for the treatment of cancer |
|
• |
Demonstrate interventions to effectively prevent or manage toxicities of ICIs and ICI combination therapies |
|
• |
Distinguish best practices for managing patients on ICIs during the coronavirus disease 2019 pandemic |
|
• |
Develop an interprofessional practice model aimed to improve outcomes in patients receiving ICIs |
|
|
|
Agenda |
|
|
Introduction (5 minutes) Presentation (75 minutes) Conclusions & Question & Answer Session (10 minutes) |
|
|
How to Earn Credit Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor. |
||||||||||||
|
Required Computer Hardware/Software Please ensure the computer system you plan to use meets the following minimum requirements: |
||||||||||||
|
||||||||||||
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate
Institute for Medicine and Postgraduate Healthcare Education. Postgraduate Institute for Medicine is jointly
accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for
Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing
education for the healthcare team.
| ||||||||||||
|
||||||||||||
| UAN: 0430-0000-20-107-L01-P | ||||||||||||
|
Continuing Nursing Education The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 0.7 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses. | ||||||||||||
|
Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. | ||||||||||||
|
||||||||||||
|
